In short, we revealed for the first time that the circHIPK3/miR-637/AKT1 regulatory pathway may be related to the tumorigenesis and growth of gastric cancer, our research results provide a potential therapeutic target for GC. This evidence concerns the gene AKT1 and gastric cancer.